Literature DB >> 17321600

Leishmania-specific isotype levels and their relationship with specific cell-mediated immunity parameters in canine leishmaniasis.

Alhelí Rodríguez-Cortés1, Hugo Fernández-Bellón, Antonio Ramis, Lluís Ferrer, Jordi Alberola, Laia Solano-Gallego.   

Abstract

In the current retrospective study, Leishmania infantum-specific IgG, IgA and IgM levels were determined by ELISA in 106 untreated dogs with clinically-patent leishmaniasis (Sx) and in 171 clinically healthy dogs (Asx) from Spain to investigate the relationship between these Ig isotypes and clinical status. In addition, we studied if different Leishmania-specific humoral pattern exists between Asx dogs with and without cellular mediated immunity (CMI). Fifty-six dogs were assessed by means of lymphoproliferation assay (LPA), interferon production (IFN) and leishmanin skin test (LST), 71 dogs by means of both LPA and IFN and 44 only by LST. Both Sx and Asx dogs produced Leishmania-specific IgG, IgA and IgM antibodies, however the levels and proportion of positive dogs for each Ig isotype were significantly higher in Sx than in Asx ones (P<0.001). Analysis of immunological profiles determined for each cellular technique (positive and negative cellular response for each technique combined with positive or negative specific humoral response) showed that Asx dogs constituted a high heterogeneous group. No correlations were observed between CMI tests and specific IgG or IgM levels. However, a significant inverse correlation was demonstrated between specific IgA levels and LPA response (Spearman's r=-0.220; P=0.035). In general, the low correlation detected between CMI tests and isotype levels might indicate that the immune response is not strongly polarized in the majority of Asx dogs. Additionally, this study suggests that dogs developing T-cell response are probably able to avoid the dissemination of the parasite at least to mucosal surfaces and, as a consequence, to produce low or background specific IgA levels. Further studies are needed to investigate the relationship between specific IgA and parasite load, especially at mucosal site.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17321600     DOI: 10.1016/j.vetimm.2007.01.015

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  13 in total

1.  Genome-Wide Association Study of Cell-Mediated Response in Dogs Naturally Infected by Leishmania infantum.

Authors:  Luís F S Batista; Yuri T Utsunomiya; Thaís B F Silva; Raíssa A Dias; Thaise Y Tomokane; Acácio D Pacheco; Vânia L R da Matta; Fernando T Silveira; Mary Marcondes; Cáris M Nunes; Márcia D Laurenti
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

2.  Dynamics and predictive potential of antibodies against insect-derived recombinant Leishmania infantum proteins during chemotherapy of naturally infected dogs.

Authors:  Felicitat Todolí; Inmaculada Galindo; Silvia Gómez-Sebastián; Mariano Pérez-Filgueira; José M Escribano; Jordi Alberola; Alhelí Rodríguez-Cortés
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

3.  Humoral and in vivo cellular immunity against the raw insect-derived recombinant Leishmania infantum antigens KMPII, TRYP, LACK, and papLe22 in dogs from an endemic area.

Authors:  Felicitat Todolí; Laia Solano-Gallego; Rafael de Juan; Pere Morell; Maria Del Carmen Núñez; Rodrigo Lasa; Silvia Gómez-Sebastián; José M Escribano; Jordi Alberola; Alhelí Rodríguez-Cortés
Journal:  Am J Trop Med Hyg       Date:  2010-12       Impact factor: 2.345

4.  Recombinant Cysteine Proteinase B from Leishmania braziliensis and Its Domains: Promising Antigens for Serodiagnosis of Cutaneous and Visceral Leishmaniasis in Dogs.

Authors:  A E Bivona; L Czentner; A Sanchez Alberti; N Cerny; A C Cardoso Landaburu; C Nevot; O Estévez; J D Marco; M A Basombrio; E L Malchiodi; S I Cazorla
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

5.  Leishmania infection: laboratory diagnosing in the absence of a "gold standard".

Authors:  Alhelí Rodríguez-Cortés; Ana Ojeda; Olga Francino; Laura López-Fuertes; Marcos Timón; Jordi Alberola
Journal:  Am J Trop Med Hyg       Date:  2010-02       Impact factor: 2.345

6.  Application of an improved enzyme-linked immunosorbent assay method for serological diagnosis of canine leishmaniasis.

Authors:  Nuno Santarém; Ricardo Silvestre; Luís Cardoso; Henk Schallig; Steven G Reed; Anabela Cordeiro-da-Silva
Journal:  J Clin Microbiol       Date:  2010-02-17       Impact factor: 5.948

7.  Immunologic indicators of clinical progression during canine Leishmania infantum infection.

Authors:  Paola M Boggiatto; Amanda E Ramer-Tait; Kyle Metz; Erin E Kramer; Katherine Gibson-Corley; Kathleen Mullin; Jesse M Hostetter; Jack M Gallup; Douglas E Jones; Christine A Petersen
Journal:  Clin Vaccine Immunol       Date:  2009-12-23

8.  Transcription of Toll-Like Receptors 2, 3, 4 and 9, FoxP3 and Th17 Cytokines in a Susceptible Experimental Model of Canine Leishmania infantum Infection.

Authors:  Shazia Hosein; Alhelí Rodríguez-Cortés; Damer P Blake; Karin Allenspach; Jordi Alberola; Laia Solano-Gallego
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

9.  Early reduction of Leishmania infantum-specific antibodies and blood parasitemia during treatment in dogs with moderate or severe disease.

Authors:  Laia Solano-Gallego; Laura Di Filippo; Laura Ordeix; Marta Planellas; Xavier Roura; Laura Altet; Pamela Martínez-Orellana; Sara Montserrat
Journal:  Parasit Vectors       Date:  2016-05-10       Impact factor: 3.876

10.  Insights on adaptive and innate immunity in canine leishmaniosis.

Authors:  Shazia Hosein; Damer P Blake; Laia Solano-Gallego
Journal:  Parasitology       Date:  2016-04-20       Impact factor: 3.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.